FOXM1: An emerging master regulator of DNA damage response and genotoxic agent resistance

por Zona, Stefania, Bella, Laura, Burton, Matthew J., Nestal de Moraes, Gabriela, Lam, Eric W.-F.
Publicado 2014

Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance

por Nestal de Moraes, Gabriela, Bella, Laura, Zona, Stefania, Burton, Matthew J., Lam, Eric W.-F.
Publicado 2016

SUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cells

por Nestal de Moraes, Gabriela, Ji, Zongling, Fan, Lavender Y.-N., Yao, Shang, Zona, Stefania, Sharrocks, Andrew D., Lam, Eric W.-F.
Publicado 2018

Regulation of PERK expression by FOXO3: a vulnerability of drug-resistant cancer cells

por Alasiri, Glowi, Jiramongkol, Yannasittha, Zona, Stefania, Fan, Lavender Y. -N., Mahmud, Zimam, Gong, Gyungyub, Lee, Hee Jin, Lam, Eric W. -F.
Publicado 2019

A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2

por Leung, Man-Hong, Tsoi, Ho, Gong, Chun, Man, Ellen PS, Zona, Stefania, Yao, Shang, Lam, Eric W.-F., Khoo, Ui-Soon
Publicado 2020

EP300 and SIRT1/6 Co-Regulate Lapatinib Sensitivity Via Modulating FOXO3-Acetylation and Activity in Breast Cancer

por Mahmud, Zimam, Gomes, Ana R., Lee, Hee Jin, Aimjongjun, Sathid, Jiramongkol, Yannasittha, Yao, Shang, Zona, Stefania, Alasiri, Glowi, Gong, Gyungyub, Yagüe, Ernesto, Lam, Eric W.-F.
Publicado 2019

Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer

por Wahba, John, Natoli, Marina, Whilding, Lynsey M., Parente-Pereira, Ana C., Jung, Youngrock, Zona, Stefania, Lam, Eric W.-F., Smith, J. Richard, Maher, John, Ghaem-Maghami, Sadaf
Publicado 2018

FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance

por Intuyod, Kitti, Saavedra-García, Paula, Zona, Stefania, Lai, Chun-Fui, Jiramongkol, Yannasittha, Vaeteewoottacharn, Kulthida, Pairojkul, Chawalit, Yao, Shang, Yong, Jay-Sze, Trakansuebkul, Sasanan, Waraasawapati, Sakda, Luvira, Vor, Wongkham, Sopit, Pinlaor, Somchai, Lam, Eric W.-F.
Publicado 2018

Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resista...

por Intuyod, Kitti, Saavedra-García, Paula, Zona, Stefania, Lai, Chun-Fui, Jiramongkol, Yannasittha, Vaeteewoottacharn, Kulthida, Pairojkul, Chawalit, Yao, Shang, Yong, Jay-Sze, Trakansuebkul, Sasanan, Waraasawapati, Sakda, Luvira, Vor, Wongkham, Sopit, Pinlaor, Somchai, Lam, Eric W.-F.
Publicado 2021

FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance

por Khongkow, Pasarat, Karunarathna, Upekha, Khongkow, Mattaka, Gong, Chun, Gomes, Ana R., Yagüe, Ernesto, Monteiro, Lara J., Kongsema, Mesayamas, Zona, Stefania, Man, Ellen P. S., Tsang, Janice W.-H., Coombes, R. Charles, Wu, Kou-Juey, Khoo, Ui-Soon, Medema, René H., Freire, Raimundo, Lam, Eric W.-F.
Publicado 2013